A Multicenter Clinical Study of Yijing Keli in the Treatment of Ovarian Aging

Ovarian Aging Clinical Trial

Official title: The Efficacy and Safety of Chinese Herbal Compound Yijing Keli in the Treatment of Ovarian Aging: A Multicenter and Prospective Study.

Status Recruiting

Clinical Trial Summary

Ovarian aging (OA) seriously affects the physical and mental health of women. Nowadays, Chinese herbs have huge appeal and potential in treating OA. We have created a new Chinese herbal combination Yijing Keli, whereas its safety and efficacy still need to be validated. Hence, we will perform a population-based, multicenter study to confirm the safety and efficacy of Yijing Keli in therapy of OA. We aim to provide a solid evidence for TCM in therapy of OA.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Ovarian Aging

• NCT number: NCT06271928
• Study type: Interventional
• Source: Tongji Hospital
• Contact: jinjin zhang, professor
• Phone: +8683663078
• Email: jinjinzhang@tjh.tjmu.edu.cn
• Status: Recruiting
• Phase: Early Phase 1
• Start date: October 1, 2021
• Completion date: January 1, 2025